T Hickish
Overview
Explore the profile of T Hickish including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
61
Citations
2001
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
21.
Ross P, Nicolson M, Cunningham D, Valle J, Seymour M, Harper P, et al.
J Clin Oncol
. 2002 Apr;
20(8):1996-2004.
PMID: 11956258
Purpose: We report the results of a prospectively randomized study that compared the combination of epirubicin, cisplatin, and protracted venous-infusion fluorouracil (PVI 5-FU) (ECF) with the combination of mitomycin, cisplatin,...
22.
Iveson T, Hickish T, Schmitt C, Van Cutsem E
Eur J Cancer
. 2000 Feb;
35(13):1796-804.
PMID: 10673994
In a recent multicentre, randomised, controlled, open-label study (Rougier and colleagues, Lancet 1998, 352, 1407-1412), irinotecan significantly increased survival without any deterioration in quality of life compared with best-estimated infusional...
23.
Waters J, Norman A, Cunningham D, Scarffe J, Webb A, Harper P, et al.
Br J Cancer
. 1999 Jul;
80(1-2):269-72.
PMID: 10390007
We report the final results of a prospectively randomized study that compared the combination of epirubicin, cisplatin and protracted venous infusion fluorouracil (5-FU) (ECF regimen) with the standard combination of...
24.
Makris A, Powles T, Ashley S, Chang J, Hickish T, Tidy V, et al.
Ann Oncol
. 1998 Dec;
9(11):1179-84.
PMID: 9862047
Background: A prospective randomised trial was undertaken to evaluate the role of neoadjuvant chemoendocrine therapy prior to surgery in primary operable breast cancer. Patients And Methods: Three hundred nine women...
25.
Cunningham D, Powles R, Malpas J, Raje N, Milan S, Viner C, et al.
Br J Haematol
. 1998 Aug;
102(2):495-502.
PMID: 9695964
High-dose chemotherapy (melphalan) with autologous marrow stem cell support (AMSCS) results in high response rates in multiple myeloma (MM), with up to 50% of patients achieving complete remission. However, these...
26.
Beale P, Judson I, Hanwell J, Berry C, Aherne W, Hickish T, et al.
Cancer Chemother Pharmacol
. 1998 Jun;
42(1):71-6.
PMID: 9619761
Raltitrexed (Tomudex) is a specific inhibitor of thymidylate synthase and has recently been licensed in Europe for use in the treatment of advanced colorectal carcinoma. This study evaluated the metabolism,...
27.
Middleton G, Smith I, OBrien M, Norton A, Hickish T, Priest K, et al.
Ann Oncol
. 1998 May;
9(3):269-73.
PMID: 9602260
Purpose: To evaluate the therapeutic impact of a simple combination chemotherapy regimen on symptoms related to malignant mesothelioma. Materials And Methods: Between October 1986 and June 1997, 39 patients with...
28.
Mattia E, Chichiarelli S, Hickish T, Gaeta A, Mancini C, Cunningham D, et al.
Oncogene
. 1997 Jul;
15(4):489-93.
PMID: 9242386
No abstract available.
29.
Mainwaring P, Nicolson M, Hickish T, Penson R, Joel S, Slevin M, et al.
Br J Cancer
. 1997 Jan;
76(12):1636-9.
PMID: 9413954
Two open, phase II studies were performed to evaluate the activity and toxicity of infusional topotecan in patients with advanced non-small-cell lung carcinoma (NSCLC) and advanced breast cancer who had...
30.
Webb A, Cunningham D, Scarffe J, Harper P, Norman A, Joffe J, et al.
J Clin Oncol
. 1997 Jan;
15(1):261-7.
PMID: 8996151
Purpose: We report the results of a prospectively randomized study that compared the combination of epirubicin, cisplatin, and protracted venous infusion fluorouracil (5-FU) (ECF regimen) with the standard combination of...